Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthma
Commentary – Open Access Stephanie Korn, Peter Howarth, Steven G. Smith, Robert G. Price, Steven W. Yancey, Charlene M. Prazma & Elisabeth H. Bel Respiratory Research volume 23, Article number: 45 (2022) Abstract Background Long-term use of oral corticosteroids (OCS) is associated with a risk of adverse events and comorbidities. As such, a goal in assessing the efficacy of biologics in severe asthma is often to monitor […]
Biologics and Aspirin-Exacerbated Respiratory Disease
Naveed Saleh The following article is a part of conference coverage from the American Academy of Allergy, Asthma & Immunology Annual Meeting, being held in Phoenix, Arizona, from February 25 to 28, 2022. The team at Pulmonology Advisor will be reporting on the latest news and research conducted by leading experts in the field. Check back for more […]
Gastroesophageal Reflux Disease in Patients With Severe Asthma
Sheila Jacobs There is a need for research into novel therapies for gastroesophageal reflux disease (GERD) in patients with severe asthma, given that GERD is a known contributor to exacerbation frequency and poor quality of life. The current analysis used a combination of in vitro and ex vivo approaches to elucidate further the underlying mechanisms […]